NCT04532645 2025-09-23
OVAL-1
AstraZeneca
Completed
Clinical Trials
7 trialsNCT04152941 2023-09-06
RETROLA
ARCAGY/ GINECO GROUP
Completed
NCT05440578 2022-07-01
First-line Olaparib Combined With Bevacizumab Maintenance Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT05081765 2021-10-18
The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib
Poznan University of Medical Sciences
Unknown
NCT05044091 2021-09-14
HOPEI
Jiangsu Cancer Institute & Hospital
Unknown
NCT04582552 2021-01-20
ROMP
Jiangsu Cancer Institute & Hospital
Unknown
NCT02506816 2020-11-30
Polen
MedSIR
Completed